Pharmaceutical industry news

Israeli biotech firm picks Indiana for North American headquarters

Clearmind Medicine Stock Slides Friday: What's Happening?

Huntsville biotech company Diatherix Laboratories to close, 55 jobs affected

A potentially blinding eye disease has no FDA-approved therapy. Tarsus bought a company developing one.

Jeol launches benchtop scanning electron microscope

A year after Big Pharma’s pull-back from the UK, what's changed?

AbbVie’s etentamig cuts risk of progression by 60% in Phase 3 multiple myeloma trial

Thyroid Medication Lot Recalled Nationwide

Roche gets Phase 3 trial waiver for higher dose of multiple sclerosis drug

2026 Kyoto University Amgen Scholars Program concludes

LIFEPAK ® 35 Monitor/Defibrillator

During production of LP35, Stryker identified that certain printer and modem access port connectors...

Imager™ II Angiographic Catheter

Boston Scientific is initiating removal of Imager II Angiographic Catheters (“Catheters”) due to a m...

GORE® VIABAHN® Endoprosthesis with PROPATEN Bioactive

Gore has identified through quality control testing that some VIABAHN® devices were processed using...

VRXA 424B Filings - Veraxa Biotech AG SEC 424B

Finance veteran behind CHF 30B portfolios joins Veraxa Biotech (VRXA) as CFO

Veraxa Biotech names Raju Willener as chief financial officer

H.C. Wainwright reiterates Legend Biotech stock rating at buy

DIMERIX SECURES A$34 MILLION NON-DILUTIVE FACILITY TO FUND KEY CLINICAL MILESTONES

Acepodia Announces FDA Clearance of IND Application for ACE723, a Novel Dual-Payload Antibody-Drug Conjugate

From drug substance to drug product: why integration matters in modern pharmaceutical development

Lipofit Extreme Fat Burner Recall: FDA Finds Toxic DNP and Hidden Drug

Govt launches BIO-NIVESH to drive private capital into biotech startups

The PIPAC pilot validating API platform

Eli Lilly pharmaceutical plant in Upper Macungie takes another step forward

Ultragenyx Pharmaceutical (NASDAQ:RARE) Rating Lowered to "Hold" at Royal Bank Of Canada

FDA Intensifies Food Safety Checks Across Goa

Huntsville biotech company to close, laying off 55 workers

Auftakt von AI4CancerCure.NRW: 32,5 Millionen Euro gehen für vernetzte Krebsforschung nach Essen

CORDIS project: Organoid technologies for disease modeling, drug discovery and development for rare diseases

CORDIS project: EUROPEAN RARE DISEASES RESEARCH ALLIANCE

CORDIS project: UnderstandiNg fraIlty tOwards a future of healthy ageiNg

CORDIS project: Next-Generation X-Ray Laser Light Sources

Bright Minds Biosciences Stock Slides 4.82% as Biotech Volatility Bites: Is More Downside Pressure Ahead for CN:DRUG?

PerkinElmer acquires SimoTech to expand pharma manufacturing automation

UBS raises Teva Pharmaceutical stock price target on celiac progress

Ionis nets Zanvastro US approval in first for Alexander disease

Trials by design: inside the new good clinical practice guideline

The nitrosamine saga: how one impurity rewrote global quality rules

La AEMPS informa de un fallo en determinados respiradores Newport HT70 Plus y piezas de recambio PCBA

Partnership to identify novel drug targets in neurological diseases

Kylo-11’s 97% Lp(a) Reduction from a Single Dose Rewrites the Durability Standard for siRNA Cardiovascular Trials

Your Questions Answered: The Biggest Pharma and Biotech Stories This Week

Superluminal raises $60 million to take obesity drug into clinic

In Mexico, spikes in gang violence lead to rising self-harm

HPM Presenting at IQVIA Annual Controlled Substances & State Regulatory Conference (Sept. 16-18)

CEE Startup & Tech Weekly: New Capital Flows into AI, Biotech, Medtech and More

NSF launches three new science and technology centres

Professor Ada Yonath (1939–2026)

Biotech Stocks At 52-Week Highs - ATTO, HALO, IKT, TVTX, ATRC

ESPMH 2026 at ESHPM

Rakovina Therapeutics Shifts 72% of Budget to AI Cancer Programs

MyAmici and My Green Lab collaborate to improve sustainable lab purchasing

Takeda Pharmaceutical (TSE:4502) Wins MIMRYLO Approval, Is The Stock Still Trading At A Discount?

The sensors behind pharmaceutical monitoring

A discovery alone does not change a life, biotech executive says

Cell growth platform advances African Swine Fever research

Wellington Management Group LLP Reduces Stock Position in Ultragenyx Pharmaceutical Inc. $RARE

FDA approves first‑ever drug for Alexander disease

Russia has attacked a Teva pharmaceutical company warehouse in Ukraine twice

Melbourne biotech ImmunoBiota progresses $5m seed raise for world-first oral Type 1 diabetes therapy